A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease

Surgery (United States)

Volumn 156, Issue 6, 2014, Pages 1378-1386

  Asare, Elliot A ^a,b,c   Wang, Tracy S ^c   Winchester, David P ^b   Mallin, Katherine ^b   Kebebew, Electron ^d   Sturgeon, Cord ^e  

^a American Joint Committee on Cancer   (United States)

^b Cancer Programs   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SURVIVAL PREDICTION; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ANALYSIS OF VARIANCE; CLASSIFICATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FACTUAL DATABASE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TUMOR INVASION; YOUNG ADULT;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84922439155     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.08.018     Document Type: Article

References (19)

1. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg 2006;30: 872-8.
2. Ng L, Libertino JM. Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J Urol 2003;169: 5-11.
3. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, et al. Management of patients with adrenal cancer: Recommendations of an international consensus conference. Endocr Relat Cancer 2005;12: 667-80.
4. Paton BL, Novitsky YW, Zerey M, Harrell AG, Norton HJ, Asbun H, et al. Outcomes of adrenal cortical carcinoma in the United States. Surgery 2006;140: 914-20.
5. Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: Proposal for a Revised TNM Classification. Cancer 2009;115: 243-50.
6. Lughezzani G, Sun M, Perrotte P, Jeldres C, Alasker A, Isbarn H, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: A North American validation. Eur J Cancer 2010;46: 713-9.
7. Miller BS, Gauger PG, Hammer GD, Giordano TJ, Doherty GM. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbecks Arch Surg 2010;395: 955-61.
8. Macfarlane DA. Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 1958;23: 155-86.
9. Sullivan M, Boileau M, Hodges CV. Adrenal cortical carcinoma. J Urol 1978;120: 660-5.
10. Icard P, Louvel A, Chapuis Y. Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 1992;16: 753-8.
11. Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou- Sellin R, Gagel RF, et al. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery 1995;118: 1090-8.
12. AJCC Cancer Staging Manual. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2011.
13. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, et al. Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 2006;91: 2650-5.
14. Tritos NA, Cushing GW, Heatley G, Libertino JA. Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey Clinic Medical Center experience. Am Surg 2000;66: 73-9.
15. Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, et al. Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors. Cancer 2008;113: 3130-6.
16. Canter DJ, Mallin K, Uzzo RG, Egleston BL, Simhan J, Walton J, et al. Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: An analysis of the National Cancer Database. Can J Urol 2013;20: 6915-21.
17. Kutikov A, Mallin K, Canter D, Wong YN, Uzzo RG. Effects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: Analysis of the National Cancer Database. J Urol 2011;186: 805-10.
18. Berruti A, Fassnacht M, Baudin E, Hammer G, Haak H, Leboulleux S, et al. Adjuvant therapy in patients with adrenocortical carcinoma: A position of an international panel. J Clin Oncol 2010;28: E401-2.
19. Terzolo M, Daffara F, Ardito A, Zaggia B, Basile V, Ferrari L, et al. Management of adrenal cancer: A 2013 update. J Endocrinol Invest 2014;37: 207-17.